Improving Fluorouracil Chemotherapy with Novel Orally Administered Fluoropyrimidines
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 58 (Supplement) , 119-126
- https://doi.org/10.2165/00003495-199958003-00016
Abstract
During the 40 years since the initial synthesis of fluorouracil, there have been many attempts to improve fluoropyrimidine chemotherapy. These have included the utilisation of different schedules of...Keywords
This publication has 25 references indexed in Scilit:
- Recent developments in oral chemotherapy options for gastric carcinoma.Drugs, 1999
- Phase I clinical and pharmacologic study of eniluracil plus fluorouracil in patients with advanced cancer.Journal of Clinical Oncology, 1998
- Improving 5-FU with a novel dihydropyrimidine dehydrogenase inactivator.1998
- Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts.1998
- A Pilot Safety Study of Capecitabine, A New Oral Fluoropyrimidine, in Patients with Advanced Neoplastic DiseaseTumori Journal, 1996
- Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulatorsAnti-Cancer Drugs, 1996
- 5-Ethynyluracil (776C85): a potent modulator of the pharmacokinetics and antitumor efficacy of 5-fluorouracil.Proceedings of the National Academy of Sciences, 1993
- Inhibition by oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its antitumor activity in rats.1993
- SELECTIVE EXPANSION OF 5,10-METHYLENETETRAHYDROFOLATE POOLS AND MODULATION OF 5-FLUOROURACIL ANTITUMOR-ACTIVITY BY LEUCOVORIN INVIVO1989
- Clinical Pharmacology of 5-FluorouracilClinical Pharmacokinetics, 1989